Df. Birt et al., INHIBITION OF SKIN CARCINOMAS BUT NOT PAPILLOMAS BY SPHINGOSINE, N-METHYLSPHINGOSINE, AND N-ACETYLSPHINGOSINE, Nutrition and cancer, 31(2), 1998, pp. 119-126
The sphingoid base backbones of sphingolipids are highly bioactive com
pounds that affect cell growth, differentiation, diverse cell behavior
s, and programmed cell death. Therefore, the efficacy of sphingosine (
SPH) and the analogs N-acetylsphingosine (NAS), N-methylsphingosine (N
MS), octylamine (OCT), and sterylamine (STR) in the prevention of skin
cancer was assessed in female Sencar mice by measuring effects on the
induction of epidermal ornithine decarboxylase (ODC) activity and hyp
erplasia by 12-O-tetradecanoylphorbol-13-acetate (TPA) and effects on
the induction of skin tumors by 7,12-dimethylbenz[a]anthracene (DMBA)
and TPA. ODC was measured in the shaved dorsal skin of mice treated to
pically with 0.05-20 mu mol of these compounds 30 minutes before appli
cation of 8.5 nmol of TPA in 0.2 mi of acetone. ODC activity was inhib
ited by greater than or equal to 5 mu mol of SPH and STR, greater than
or equal to 10 mu mol of NAS and NMS, and 20 mu mol of OCT. In contra
st the induction of hyperplasia was not inhibited by application of th
ese compounds 30 minutes before TPA. Two carcinogenesis studies were c
onducted with 10 nmol of DMBA as the initiator and 3.2 nmol of TPA (2x
/wk for 15 wk) as the promoter. In the first study, NAS, NMS, OCT, and
STR (0.05 and 0.5 mu mol) were applied before each TPA application. P
apilloma incidence and multiplicity were not inhibited, but NAS (0.05
mu mol) and NMS (0.05 and 0.50 mu mol) increased cancer-free survival.
In the second experiment, SPH, NAS, and NMS (0.05 and 0.5 mu mol) wer
e applied 30 minutes before each TPA treatment and twice weekly for IO
weeks after the final TPA treatment. Papilloma incidence and multipli
city were not inhibited; however, the proportion of mice without carci
noma was increased by both doses of SPH and by 0.5 mu mol of NAS. Thus
low doses of sphingolipids that were not effective in inhibiting ODC
activity, reducing hyperplasia, or preventing epidermal papilloma deve
lopment were, nonetheless, effective in inhibiting carcinoma developme
nt.